KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in ABBV — AbbVie Inc.
CIK 1021223
LOS ANGELES, CA
Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,489,925
+$4,153,230 QoQ
Shares Held
113,217
+1.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#502
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 49%
Shared 50%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $148,204,577 across 14 Drug Manufacturers - General names. ABBV ranks #2 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,338 | $78,368,363 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
113,217 | $28,489,925 | |
| 3 | JNJ |
Johnson & Johnson
|
57,018 | $14,480,861 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,634 | $8,305,469 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
50,176 | $6,339,235 | |
| 6 | AMGN |
Amgen Inc
|
11,431 | $4,139,392 | |
| 7 | AZN |
Astrazeneca PLC
|
21,789 | $4,131,630 | |
| 8 | NVO |
Novo Nordisk A S
|
28,829 | $1,382,062 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,489,925 | 113,217 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $24,336,695 | 111,898 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $27,900,227 | 122,107 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $28,720,221 | 124,040 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $24,491,073 | 131,942 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $27,223,980 | 129,935 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $23,794,029 | 133,900 | Shares | Defined | 2025-02-21 | |
| 2024-09-30 | $27,308,324 | 138,284 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $24,597,854 | 143,411 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,646,510 | 146,329 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $23,177,468 | 149,561 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $23,523,456 | 157,812 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $21,826,528 | 162,002 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,396,133 | 165,628 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $26,981,112 | 166,952 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,298,856 | 166,149 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $12,446,393 | 81,264 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,138,852 | 81,049 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $429,082 | 3,169 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $339,790 | 3,150 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $354,816 | 3,150 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $340,893 | 3,150 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $331,736 | 3,096 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $271,178 | 3,096 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $284,329 | 2,896 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $219,960 | 2,887 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||